BD recalls ChloraPrep applicators lot over fungal contamination
BD has announced a voluntary worldwide recall of a single lot of ChloraPrep Clear 1mL applicators over contamination under specific …
BD has announced a voluntary worldwide recall of a single lot of ChloraPrep Clear 1mL applicators over contamination under specific …
EDX Medical has developed a new non-invasive prostate cancer test it hopes will transform diagnosis and detection of the disease. The …
Johnson & Johnson is set to resume the limited market release of the Varipulse Catheter, a treatment option for atrial …
A team from the University of Hong Kong (HKU) has developed an AI-driven imaging tool, Cyto-Morphology Adversarial Distillation (CytoMAD), which …
Vitalacy's AI-powered Virtual Care system is revolutionising patient monitoring by minimising fall risks and easing caregiver workload pressures, according to …
Bio-Rad has entered a binding offer to purchase all equity interests in French biotech Stilla Technologies. According to Bio-Rad, Stilla, which …
WhiteSwell has reported encouraging results from its DELTA-HF trial, which evaluated the minimally invasive catheter-based eLym System in treating individuals …
AI has worked its way into many industries over the past decade with no end in sight. The world of …
GeneDX is set to launch ultrarapid whole genome sequencing (WGS) for neonatal and paediatric patients in intensive care units (NICU …
Seven months after suspending sales of its weight loss balloon in France due to safety concerns, Allurion’s products are back …
Yourgene Health, a molecular diagnostics group within the Novacyt group of companies, has announced the UK launch of a fully …
InspireMD, in partnership with NAMSA, is set to initiate the pivotal, single-arm CGUARDIANS II study to assess the CGuard Prime …
Preventative health startup Prenuvo, which offers a full-body MRI scan technology lauded by celebrities, has raised $120m in funding. The US-based …
Artera and Tempus are collaborating to expand access to Artera’s AI-based prostate cancer test. Currently connected to more than 50% of …
Grail has partnered with Quest Diagnostics to enable access to its Galleri multi-cancer early detection test for healthcare providers in …